Vitiligo

Compared to monotherapy with NB-UVB, combination treatments are more effective at promoting successful repigmentation and preventing treatment failure in vitiligo patients. Vitiligo is characterized as an autoimmune disorder. Some management guidelines regarding vitiligo suggest the…

Antiseptic tulle gras dressing is an effective approach to applying an ultrathin skin graft template on depigmented areas in recalcitrant vitiligo. This method helps prevent graft displacement and deformity (curling and wrinkling) of its edges.…

The emergence of macular IGH-like lesions is a reversible and rare adverse effect following photochemotherapy in vitiligo patients. Phototherapy is a safe and effective treatment for stable vitiligo in the pediatric population. A rare side…

Vitiligo is characterized by underlying immunometabolism mechanisms. These serve as the basis for understanding the pathogenic mechanisms and the development of novel therapeutic approaches. Vitiligo is an autoimmune depigmenting skin disorder associated with selective melanocyte…

Melanoma Inhibitory Activity (MIA) is an effective therapeutic target for recalcitrant non-segmental vitiligo, in combination with oral antioxidant medications and UVA or sun exposure. Vitiligo is characterized by acquired autoimmune depigmentation of the skin. Studies…